ImmunityBio amends stock sale agreement to authorize $460M offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/31/2026
- Wall St set for lower open as Middle East clashes revive rate-hike speculation
- The Warsh pivot markets didn't expect
- Oil rises over 2% as US and Iran resume military attacks
- Energy stocks rally as fresh U.S.-Iran attacks drive oil prices higher
- BofA turns S&P 500 signals from red to yellow: What to buy now
- GameStop posts higher income despite revenue drop in Q2 2026
- At least eight die, 18 missing after ferry capsizes off North Cyprus
- Manhunt underway after woman killed, several injured at Swiss rave shooting
- Aon close to acquiring USI Insurance from KKR in $17 billion deal, WSJ reports
- RedHill sells Talicia to Apotex for $18M upfront plus milestones
Form 424B5 ImmunityBio, Inc.
December 29, 2025 6:02 AM ESTTable of Contents
Filed Pursuant to Rule 424(b)(5)
File No. 333-278770
PROSPECTUS SUPPLEMENT
(To Prospectus dated April 17, 2024)
... More
Form 8-K ImmunityBio, Inc. For: Dec 23
December 29, 2025 6:02 AM ESTfalse 0001326110 0001326110 2025-12-23 2025-12-23... More
